#iPS cell therapy
Total 2 articles
EconomyEN
The 20-Year Wait Is Over: World's First iPS Cell Therapies Near Reality
Japan moves closer to approving the world's first commercial iPS cell-based treatments for Parkinson's and heart disease, marking a historic moment in regenerative medicine.
EconomyEN
The 20-Year Wait Is Over: World's First iPS Therapy Hits Market
Japan approves world's first commercial iPS cell therapies for heart disease and Parkinson's. A breakthrough that could reshape medicine globally, but questions remain about accessibility and competition.
